ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280 | -99.9% | 2,995 | +69.1% | 0.03% | +86.7% |
Q1 2022 | $208,000 | -56.6% | 1,771 | -50.2% | 0.02% | -69.4% |
Q4 2021 | $479,000 | +116.7% | 3,558 | +111.5% | 0.05% | +133.3% |
Q2 2021 | $221,000 | -19.9% | 1,682 | -5.9% | 0.02% | -55.3% |
Q3 2020 | $276,000 | -56.3% | 1,787 | -67.4% | 0.05% | +27.0% |
Q2 2019 | $631,000 | +173.2% | 5,483 | +179.2% | 0.04% | +184.6% |
Q1 2019 | $231,000 | +1.8% | 1,964 | -43.5% | 0.01% | +8.3% |
Q1 2018 | $227,000 | – | 3,478 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |